Becker's Healthcare January 13, 2025
Alexandra Murphy

The prices of the 25 most expensive brand-named drugs covered by Medicare Part D have nearly doubled, rising by an average of 98% since they entered the market, according to a new analysis by the AARP Public Policy Institute.

These drugs, which were responsible for nearly $50 billion in total Medicare Part D spending in 2022, are used by over 7 million enrollees.

The report highlights a trend of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Insurance, Medicare, Pharma, Pharma / Biotech, Survey / Study, Trends
Podcast: The Scope of Medicare Fraud
Study reveals cost differences between Medicare Advantage and traditional Medicare patients in cancer drugs
Harnessing AI to reduce Medicare errors, improve accuracy, and ease physician burnout
Report: Prices for top Medicare Part D drugs nearly doubled since entering the market
Pharmacy benefit managers steer Medicare patients to use their own pharmacies

Share This Article